Between 2002 and 2013, the price of insulin more than tripled, to more than $700 per patient. A federal lawsuit accuses three insulin manufacturers — Eli Lilly, Novo Nordisk and Sanofi — of conspiring to raise their prices. Vermont Sen. Bernie Sanders is calling for a federal investigation, alleging collusion among the companies. The drug makers deny the allegations. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.